C-reactive protein is an independent predictor for carotid artery intima-media thickness progression in asymptomatic younger adults (from the Bogalusa Heart Study)

BMC Cardiovascular Disorders

Volumn 11, Issue , 2011, Pages

  Toprak, Ahmet ^a   Kandavar, Ramprasad ^a   Toprak, Demet ^a   Chen, Wei ^b   Srinivasan, Sathanur ^b   Xu, Ji H ^b   Anwar, Asif ^a   Berenson, Gerald S ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane Center for Cardiovascular Health   (United States)

Author keywords

C reactive protein; Cardiovascular risk; Carotid artery intima media thickness progression; Epidemiology; Young adults

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH SENSITIVITY C REACTIVE PROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AFRICAN AMERICAN; AGE; ANTHROPOMETRIC PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CAROTID BULB; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMMON CAROTID ARTERY; COMPOSITE CAROTID ARTERY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HEIGHT RATIO; BLOOD; CAROTID ARTERY DISEASE; ETHNOLOGY; FOLLOW UP; HEALTH SURVEY; METABOLISM; METHODOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; UNITED STATES;

ADULT; AFRICAN AMERICANS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOUISIANA; MALE; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84855176016     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-11-78     Document Type: Article

References (31)

1. Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008, 21:93-111. quiz 189-90, 10.1016/j.echo.2007.11.011, 18261694.
2. Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 2003, 290:2271-6. 10.1001/jama.290.17.2271, 14600185.
3. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998, 338:1650-6. 10.1056/NEJM199806043382302, 9614255.
4. Johnson HM, Douglas PS, Srinivasan SR, et al. Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study. Stroke 2007, 38:900-5. 10.1161/01.STR.0000258003.31194.0a, 17272779.
5. Stensland-Bugge E, Bonaa KH, Joakimsen O, Njolstad I. Sex differences in the relationship of risk factors to subclinical carotid atherosclerosis measured 15 years later: the Tromso study. Stroke 2000, 31:574-81. 10.1161/01.STR.31.3.574, 10700488.
6. Hashimoto H, Kitagawa K, Hougaku H, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001, 104:63-7. 10.1161/hc2601.091705, 11435339.
7. Sander D, Schulze-Horn C, Bickel H, et al. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke 2006, 37:351-7. 10.1161/01.STR.0000199034.26345.bc, 16373634.
8. Hashimoto H, Kitagawa K, Hougaku H, Etani H, Hori M. C-reactive protein predicts carotid atherosclerosis progression in mild to moderate risk and middle-aged patients. Clin Invest Med 2006, 29:77-82.
9. Lorenz MW, Karbstein P, Markus HS, Sitzer M. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke 2007, 38:1774-9. 10.1161/STROKEAHA.106.476135, 17446427.
10. Elias-Smale SE, Kardys I, Oudkerk M, Hofman A, Witteman JC. C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis 2007, 195:e195-202. 10.1016/j.atherosclerosis.2007.07.006, 17714718.
11. Sander K, Horn CS, Briesenick C, Sander D. High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: the INVADE Study. Stroke 2007, 38:2881-6. 10.1161/STROKEAHA.106.481531, 17885262.
12. Hodis HN, St John JA, Xiang M, et al. Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial). Am J Cardiol 2008, 101:1131-3. 10.1016/j.amjcard.2007.09.120, 18394446.
13. The Bogalusa Heart Study 20th Anniversary Symposium. Am J Med Sci 1995, 310:S1-S138. 10.1097/00000441-199507000-00001, 7503110.
14. Berenson GS, McMahan CA, Voors AV, et al. Cardiovascular Risk Factors in Children-The Early Natural History of Atherosclerosis and Essential Hypertension. 1980, 47-123. New York: Oxford University Press, Andrews C, Hester HE.
15. High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. The ARIC Study Group. J Neuroimaging 1991, 1:168-72.
16. Tang R, Hennig M, Thomasson B, et al. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2000, 18:197-201. 10.1097/00004872-200018020-00010, 10694188.
17. Juonala M, Viikari JS, Ronnemaa T, et al. Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2006, 26:1883-8. 10.1161/01.ATV.0000228818.11968.7a, 16728658.
18. Willeit J, Kiechl S. Biology of arterial atheroma. Cerebrovasc Dis 2000, 10(Suppl 5):1-8.
19. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102:2165-8.
20. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 2005, 46:937-54. 10.1016/j.jacc.2005.03.074, 16168274.
21. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-43. 10.1056/NEJM200003233421202, 10733371.
22. Blake GJ, Rifai N, Buring JE, Ridker PM. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003, 108:2993-9. 10.1161/01.CIR.0000104566.10178.AF, 14638538.
23. Cao JJ, Thach C, Manolio TA, et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 2003, 108:166-70. 10.1161/01.CIR.0000079160.07364.6A, 12821545.
24. Curb JD, Abbott RD, Rodriguez BL, et al. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003, 107:2016-20. 10.1161/01.CIR.0000065228.20100.F7, 12681999.
25. Koenig W, Lowel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004, 109:1349-53. 10.1161/01.CIR.0000120707.98922.E3, 15023871.
26. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-97. 10.1056/NEJMoa032804, 15070788.
27. Tanne D, Benderly M, Goldbourt U, et al. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 2006, 37:1720-24. 10.1161/01.STR.0000227004.08182.bf, 16741173.
28. Bots MJ, Schipper CM, Koudstaal PJ, et al. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation 2006, 114:1591-98. 10.1161/CIRCULATIONAHA.106.619833, 17015791.
29. Torzewski M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000, 20:2094-9. 10.1161/01.ATV.20.9.2094, 10978254.
30. Wang CH, Li SH, Weisel RD, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003, 107:1783-90. 10.1161/01.CIR.0000061916.95736.E5, 12665485.
31. Li L, Roumeliotis N, Sawamura T, Renier G. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction. Circ Res 2004, 95:877-83. 10.1161/01.RES.0000147309.54227.42, 15472120.